Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Capital Expenditures (2025)

Historic Capital Expenditures for Mereo BioPharma (MREO) over the last 1 years, with Q1 2025 value amounting to $20000.0.

  • Mereo BioPharma's Capital Expenditures changed N/A to $20000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $20000.0, marking a year-over-year change of. This contributed to the annual value of $13000.0 for FY2022, which is 9819.74% down from last year.
  • Per Mereo BioPharma's latest filing, its Capital Expenditures stood at $20000.0 for Q1 2025.
  • Mereo BioPharma's 5-year Capital Expenditures high stood at $20000.0 for Q1 2025, and its period low was $20000.0 during Q1 2025.